Blue Earth Diagnostics

Blue Earth Diagnostics is owned by Bracco Group. Bracco Group has a direct presence in 2 countries.

They are in:

• Healthcare67%
• Biotechnology33%

View the org chart displaying its 9 main executives

Most searched biographies at Blue Earth Diagnostics

• David Gauden, Chief Executive Officer
• Matt Morrison, Head of Operations & Supply Chain
• Chelsea Roche, General Counsel and Company Secretary

Create your alert
to follow the executive moves at Blue Earth Diagnostics.

Bracco Group has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Blue Earth Diagnostics

Social media about Blue Earth Diagnostics

• Blue Earth Diagnostics on Wikipedia, Google News & Yahoo Finance
• Blue Earth Diagnostics on LinkedIn, Twitter & YouTube

Contact by email its executives including David Gauden

Call Blue Earth Diagnostics at +44 18...

View the org chart

Register to receive your alert

Report an error